About
Webinar
Agenda
  • 5.30pm : Registration
  • 6:00pm : Opening Remark by Richard Abela
  • 6:05pm : Welcome and Introduction (Chair) by Emeritus Prof Dr Chan Siew Pheng
  • 6.10pm : Role of Oral Semaglutide across the spectrum of Diabetes Journey by Prof Dr Norlela Sukor, Dr Siti Harnida Md Isa, Dr Hew Fen Lee
  • Panel Case Discussion:
  • Newly diagnosed T2D as first-line-monotherapy
  • T2D uncontrolled on oral antidiabetic drug
  • Optimizing outcome for patients on insulin
  • 6:50pm : Efficacy and Safety in patients with T2D and renal impairment by Dr Yew Shiong Shiong, Dr Tan Li Ping, Dr Ng Eng Khim
  • Panel Case Discussion
  • Optimizing outcomes for DKD patients
  • Obese DKD patients
  • Safety and Efficacy in relatively poor eGFR
  • 7:30pm : Effects on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes by Dr Ng Wai Kiat, Dr Emily Tan Lay Koon
  • Panel Case Discussion
  • Mode of Action: GLP-1RA and the Heart
  • Optimising outcomes in High CV Risk T2D Patients
  • Post myocardial infarction patient
  • 8:10pm : Closing Remarks
Presenters
1597456957-2c8f77e3042750b9
Novo Nordisk
Y
Alof KL
AV Tech
J
TECH Penang
Tech
N
Tech Johor
Tech
A
Tech Sabah
Tech
L
TECH PERAK
Tech
N
TECH PAHANG
TECH
N
TECH KELANTAN
TECH